Phytopharm plc
Annual Information Update
Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 31 January 2011, the following information has been published or made available to the public between 14 December 2009 and 7 February 2011 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.
1. Announcements made via the Regulatory Information Service ("RIS")
All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com
Date of publication |
Title |
1 February 2011 |
Total voting rights |
1 February 2011 |
Annual Report 2010 and notice of 2011 AGM |
19 January 2011 |
Director/PDMR shareholding |
19 January 2011 |
Director/PDMR shareholding |
14 January 2011 |
Holdings in Company |
10 January 2011 |
Holdings in Company |
7 January 2011 |
Block Listing Application |
4 January 2011 |
Total voting rights |
21 December 2010 |
Director/PDMR shareholding |
21 December 2010 |
Director/PDMR shareholding |
14 December 2010 |
Block Listing application |
30 November 2010 |
Final results |
17 November 2010 |
Research update |
3 November 2010 |
Block listing interim review |
1 November 2010 |
Preliminary results - change of date |
1 November 2010 |
Notice of preliminary results |
29 September 2010 |
Presentation at scientific conference |
18 August 2010 |
Interim management statement |
22 July 2010 |
Director/PDMR shareholding |
22 July 2010 |
Director/PDMR shareholding |
5 July 2010 |
Change of registered office |
21 June 2010 |
Appointment of Chief Executive Officer |
14 June 2010 |
Regulatory approval to begin Cogane™ Phase II trial |
24 May 2010 |
Half yearly report |
19 May 2010 |
Notice of results |
4 May 2010 |
Block listing interim review |
1 April 2010 |
Director/PDMR shareholding |
1 April 2010 |
Director/PDMR shareholding |
1 April 2010 |
Director/PDMR shareholding |
31 March 2010 |
Results of Annual General Meeting |
2 March 2010 |
Notice of Annual General Meeting |
11 February 2010 |
Interim Management Statement |
15 January 2010 |
Appointment of R & D Director |
5 January 2010 |
Holding in company |
4 January 2010 |
Total voting rights |
31 December 2009 |
Director/PDMR shareholding |
31 December 2009 |
Director/PDMR shareholding |
31 December 2009 |
Director/PDMR shareholding |
31 December 2009 |
Director/PDMR shareholding |
29 December 2009 |
GM results |
22 December 2009 |
Open Offer results |
15 December 2009 |
Correction to Form of Proxy |
15 December 2009 |
Annual Information update |
14 December 2009 |
Presents data at XVIII WFN Congress |
2. Documents published or sent to Shareholders, filed with the UK Listing Authority or submitted to the FSA including those filed with the National Storage Mechanism:
Date of publication |
Title |
1 February 2011 |
Notice of 2011 Annual General Meeting |
1 February 2011 |
Annual Report 2010 |
2 June 2010 |
Interim Report 2010 |
31 March 2010 |
AGM resolutions |
2 March2010 |
Notice of Annual General Meeting |
30 December 2009 |
General Meeting resolutions |
The 2010 Interim and 2010 Annual reports are available on the Company's website www.phytopharm.com
3. Documents filed at Companies House
The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ
Date of Publication |
Title |
25 January 2011 |
Form SH01 Return of allotment of shares on 14 January 2011 |
5 January 2011 |
Form SH01 Return of allotment of shares on 16 December 2010 |
16 December 2010 |
Form AR01 Annual return |
6 July 2010 |
Form AP01 Appointment of director |
6 July 2010 |
Form AD01 change of registered office address |
31 March 2010 |
Articles of Association approved by shareholders on 30 march 2010 |
31 March 2010 |
Annual General Meeting resolutions |
25 January 2010 |
Form AP01 Appointment of director |
4 January 2010 |
Form SH01 Return of allotment of shares on 29 December 2009 |
Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambs PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.
This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.
For further information, please contact:
Zoe McGowan, Company Secretary
Phytopharm plc Tel No: +44 (0)1480 437697
Further information about Phytopharm can be found on the Company's website www.phytopharm.com